CymaBay Therapeutics Inc.

Q1 2022 13F Holders

Symbol
CBAY
CUSIP
23257D103
Type
Equity
Class
COM
Num filings
128
Total reported value, excl. options
$215 M
Manager Report Date Value ($000) Shares Option Type